Substantia nigra echogenicity in progressive supranuclear palsy

Movement Disorders

Volumn 25, Issue 6, 2010, Pages 773-777

  Ebentheuer, Jens ^a   Canelo, Monica ^a   Ellen, Trautmann ^a   Trenkwalder, Claudia ^a  

^a Center of Parkinsonism and Movement Disorders   (Germany)

Author keywords

Progressive supranuclear palsy (PSP); SN hyperechogenicity; Transcranial sonography (TCS)

Indexed keywords

LEVODOPA;

AGED; ARTICLE; BRAIN THIRD VENTRICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; IMAGING SYSTEM; MALE; NEUROIMAGING; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RICHARDSON SYNDROME; SUBSTANTIA NIGRA; SYNDROME; TREATMENT RESPONSE; ULTRASOUND; ULTRASOUND TRANSDUCER;

EID: 77951827776     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22981     Document Type: Article

References (18)

1. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995;45:182-184.
2. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003;60:74-77. (Pubitemid 36070647)
3. Školoudík D, Bártová P, Herzig R. Transcranial sonography in Parkinsons disease. Aging Health 2009;5:43-49.
4. Bártová P, Školoudík D, Fadrná T, et al. Ultrasound evaluation of Substantia nigra in patients with Parkinsonian syndromes. Cesk Slov Neurol N 2007;103:653-657.
5. Walter U, Dressler D, Wolters A, Wittstock M, Greim B, Benecke R. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia. J Neurol 2006;253:448-454. (Pubitemid 43965609)
6. Walter U, Dressler D, Probst T, et al. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. Arch Neurol 2007;64:1635-1640. (Pubitemid 350106766)
7. Golbe LI. Progressive supranuclear pasly. In: Beal MF, Lang AE, Ludolph AC, editors. Neurodegenerative diseases: neurobiology, pathogenesis, and therapeutics. Cambridge, UK; New York: Cambridge University Press; 2005. p 663-681.
8. Maher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986;36:1005-1008.
9. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. a Heterogeneous Degeneration Involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
10. Richardson JC, Steele J, Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of "heterogenous system degeneration". Trans Am Neurol Assoc 1963;88:25-29.
11. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-486.
12. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105. (Pubitemid 26013790)
13. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128(Part 6):1247-1258.
14. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53:1026-1031. (Pubitemid 29442119)
15. Seidel G, Kaps M, Gerriets T, Hutzelmann A. Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging 1995;5:105-108.
16. Berg D, Roggendorf W, Schroder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002;59:999-1005. (Pubitemid 34640761)
17. Berg D, Merz B, Reiners K, Naumann M, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005;20:383-385. (Pubitemid 40613305)
18. Jellinger KA. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 2008;5:339-346.